Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antigen-specific active immunotherapy for ovarian cancer.
Paijens ST, Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, de Bruyn M, Nijman HW. Paijens ST, et al. Among authors: daemen t. Cochrane Database Syst Rev. 2018 Sep 10;9(9):CD007287. doi: 10.1002/14651858.CD007287.pub4. Cochrane Database Syst Rev. 2018. PMID: 30199097 Free PMC article. Review.
Immunologic aspect of ovarian cancer and p53 as tumor antigen.
Nijman HW, Lambeck A, van der Burg SH, van der Zee AG, Daemen T. Nijman HW, et al. Among authors: daemen t. J Transl Med. 2005 Sep 15;3:34. doi: 10.1186/1479-5876-3-34. J Transl Med. 2005. PMID: 16164749 Free PMC article.
Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
Visser J, van Baarle D, Hoogeboom BN, Reesink N, Klip H, Schuuring E, Nijhuis E, Pawlita M, Bungener L, de Vries-Idema J, Nijman H, Miedema F, Daemen T, van der Zee A. Visser J, et al. Among authors: daemen t. Int J Cancer. 2006 May 15;118(10):2529-37. doi: 10.1002/ijc.21673. Int J Cancer. 2006. PMID: 16353143 Free article. Clinical Trial.
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy.
Lambeck A, Leffers N, Hoogeboom BN, Sluiter W, Hamming I, Klip H, ten Hoor K, Esajas M, van Oven M, Drijfhout JW, Platteel I, Offringa R, Hollema H, Melief K, van der Burg S, van der Zee A, Daemen T, Nijman H. Lambeck A, et al. Among authors: daemen t. Int J Cancer. 2007 Aug 1;121(3):606-14. doi: 10.1002/ijc.22710. Int J Cancer. 2007. PMID: 17415711 Free article.
128 results